Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: Use of two monoclonal antibodies to prevent graft rejection

Pediatrics

Volumn 98, Issue 3, 1996, Pages 420-428

  Jabado, Nada ^a   Le Deist, Françoise ^a   Cant, Andrew ^b   De Graeff Meeders, Elizabeth R ^c   Fasth, Anders ^d   Morgan, Gareth ^e   Vellodi, Ashok ^f   Hale, Geoff ^g   Bujan, Wilhelm ^h   Thomas, Caroline ^a   Cavazzana Calvo, Marina ^a   Wijdenes, John ⁱ   Fischer, Alain ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^f Westminster Children's Hospital   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

ⁱ Diaclone   (France)

Author keywords

antiadhesion molecules; bone marrow transplantation; HLA mismatched transplants; inborn errors; T cell depletion

Indexed keywords

BUSULFAN; CD2 ANTIGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; LYMPHOCYTE ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD 2; MONOCLONAL ANTIBODY CD11A; UNCLASSIFIED DRUG;

ALBERS SCHOENBERG DISEASE; ARTICLE; BONE MARROW TRANSPLANTATION; CHEDIAK HIGASHI SYNDROME; CHILD; CHIMERA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG MIXTURE; FEVER; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HISTIOCYTOSIS; HLA SYSTEM; HUMAN; INBORN ERROR OF METABOLISM; INFANT; LEUKOCYTE ADHERENCE; LYMPHOCYTOSIS; MULTICENTER STUDY; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CHIMERA; EUROPE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HLA ANTIGENS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; LYMPHOCYTE DEPLETION; PROSPECTIVE STUDIES; SEVERE COMBINED IMMUNODEFICIENCY; TISSUE DONORS;

EID: 9544240330     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Reisner Y, Kapoor N, Kirpatrick D, et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, and DR incompatible parental marrow cells fractioned by soybean agglutinin and steep red blood cells. Blood. 1983;61:341-348
2. Fischer A, Griscelli C, Friedrich W, et al. Bone marrow transplantation for immunodeficiencies and osteopetrosis: European survey 1968-1985. Lancet. 1986;2:1080-1083
3. O'Reilly RJ, Keever CA, Small TN, Brochstein J. The use of HLA-nonidentical T cell-depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodef Rev. 1990;1:273-310
4. Brochstein AJ, Gilio AP, Ruggiero M, et al. Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome. J Pediatr. 1991;119:907-912
5. Mullen CA, Anderson KD, Blaese RM. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases. Blood. 1993;82:2961-2966
6. Thomas C, Le Deist F, Cavazzana-Calvo M, et al. Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency. Blood. 1995;86:1629-1635
7. Le Deist F, Blanche S, Keable S, et al. Successful HLA nonidentical bone marrow transplantation in three patients with leukocyte adhesion deficiency. Blood. 1989;74:512-516
8. Springer TA, Dustin ML, Kishimoto TK, Marlin SD. The lymphocyte function associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system. Annu Rev Immunol. 1987;5:223-252
9. Bierer BE, Emerson SG, Antin J, et al. Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation. Transplantation. 1988;46:835-839
10. Fischer A, Griscelli C, Blanche S, et al. Prevention of graft failure by an anti-LFA-1 monoclonal antibody in HLA-mismatched bone marrow transplantation. Lancet. 1986;2:1058-1061
11. Fischer A, Friedrich W, Fasth A, et al. Reduction of graft failure by a monoclonal antibody (anti-LFA-1, CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: an EGID-EBMT report. Blood. 1991;2: 249-256
12. Moingeon P, Chang HC, Sayre PH, et al. The structural biology of CD2. Immunol Rev. 1989;111:111-144
13. Bierer BE, Burakoff SJ. T-lymphocyte activation: the biology and function of CD2 and CD4. Immunol Rev. 1989;111:267-294
14. Kato K, Koyanagi M, Okada H, et al. CD48 is a counterreceptor for mouse CD2 and is involved in T cell activation. J Exp Med. 1992;176: 1241-1250
15. Hahn WC, Menu E, Bothwell AL, Sims PJ, Bierer BE. Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59. Science. 1992;256:1805-1807
16. Dustin ML, Springer TA. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol. 1991;9: 27-57
17. Miller GT, Hochman P, Meier W, et al. Specific interaction of lymphocyte function associated antigen 3 with CD2 can inhibit T cell responses. J Exp Med. 1993;178:211-222
18. Palacios R, Martinez-Maza O. Is the E receptor on human lymphocytes a "negative signal receptor"? J Immunol. 1982;129:2479-2485
19. Ohno H, Nakamura T, Yagita H, Okumura K, Taniguchi M, Saito T. Induction of a negative signal through CD2 during antigen specific T cell activation. J Immunol. 1991;147:2100-2106
20. Gückel B, Berek C, Lutz M, Altevogt P, Schirrmacher V, Kyewski BA. Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J Exp Med. 1991;174:957-968
21. Stephan JL, Donadieu J, Le Deist F, Blanche S, Griscelli C, Fischer A. Treatment of familial hemophagocytic lymphohistiocytosis with anti-thymocyte globulins, steroids, and cyclosporine A. Blood. 1993;8: 2319-2323
22. Fischer A, Durandy A, De Villartay JP, et al. HLA haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporine A. Blood. 1986;67:444-449
23. Hale G, Bright S, Chumbley G, Hoang T, et al. Removal of T cells from bone marrow for transplantation: a monoclonal antilymphocyte antibody that fixes human complement. Blood. 1983;62:873-882
24. Ferez N, Le Deist F, Chatenoud L, Chanteloup N, Griscelli C, Fischer A. In vivo infusion of anti-LFA-1 antibody in HLA nonidentical bone marrow transplantation in children: serum concentrations and biological effects. Bone Marrow Transplant. 1989;4:379-384
25. Glucksberg H, Storb R, Fefer A. Clinical manifestations of GVHD in human recipients of marrow from HLA matched sibling donors. Transplantation. 1974;18:295-301
26. Stephan JL, Vlekova V, LeDeist F, et al. Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients. J Pediatr. 1993;123:564-572
27. Frame JN, Collins NH, Cartagena T. T cell depletion of human bone marrow. Transplantation. 1989;47:984-988
28. Novotny JR, Hertenstein B, Bunjes D, et al. Ex Vivo T Cell Depletion With Campath-1 M Reduces Early Hematopoietic Cells as Shown in Limiting Dilution Type Long-Term Bone Marrow Culture. 1994:26. Abstract 10
29. Hale G, Cobbold S, Waldmann H. T cell depletion with Campath-1 in allogeneic bone marrow transplantation. Transplantation. 1988;45: 753-759
30. Gilleece MH, Dexter TM. Effect of Campath-1H antibody on human hematopoietic progenitors in vitro. Blood. 1993;82:807-812
31. Klein C, Lisowska-Grospierre B, Le Deist F, Fischer A, Griscelli C. Major histocompatibility class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr. 1993;123:921-928
32. Mackinnon S, Barnett L, Bourhis JH, Black P, Heller G, O'Reilly RJ. Myeloid and lymphoid chimerism after T cell-depleted bone marrow transplantation: evaluation of conditioning regimen using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. Blood. 1992;80:3235-3239
33. Qin L, Chavin KD, Lin J, Yagita H, Bromberg JS. Anti-CD2 receptor and anti-CD2 ligand (CD48) synergize to prolong allograft survival. J Exp Med. 1994;179:341-348
34. Chavin KD, Lau HT, Bromberg JS. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies. Transplantation. 1992;54:286-291
35. Bromberg JS, Chavin KD, Altevogt P, et al. Anti-CD2 monoclonal antibodies alter cell-mediated immunity in vivo. Transplantation. 1991;51: 219-225
36. Cavazzana-Calvo M, Fromont C, Le Deist F, et al. Specific elimination of alloreactive T cells by an anti-interleukin-2 receptor B chain-specific immunotoxin. Transplantation. 1990;50:1-7
37. Cavazzana-Calvo M, Stephan JL, Sarnacki S, et al. Attenuation of graftversus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination. Blood. 1994;83:288-298